









Markets
/
Stocks
/
nasdaq-kvue
/

Kenvue Inc

KVUE

16.420USD

+0.250+1.55%

Close 09/26, 16:00（ET）Quotes delayed by 15 min

31.51BMarket Cap

22.22P/E TTM



Kenvue Inc

16.420

+0.250+1.55%

Overview Company Financials Analysis

Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).

Company Info

Ticker SymbolKVUE

Company nameKenvue Inc

IPO dateMay 04, 2023

CEOMr. Kirk L. Perry

Number of employees22000

Security typeOrdinary Share

Fiscal year-endMay 04

Address1 Kenvue Way

CitySUMMIT

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code07901

Phone19088741200

Websitehttps://www.kenvue.com

Ticker SymbolKVUE

IPO dateMay 04, 2023

CEOMr. Kirk L. Perry

Company Executives

Name

Name/Position

Position

Shareholding

Change

Ms. Meredith (Meri) Stevens

Chief Operations Officer

64.44K

+5.82%

Mr. Carlton Lawson

Group President, Europe, Middle East and Africa and Latin America

56.32K

-14.66%

Dr. Caroline Tillett

Chief Scientific Officer

44.13K

+6.62%

Mr. Jan Meurer

Group President, North America

33.18K

+15.35%

Ms. Luani Alvarado

Chief People Officer

31.36K

+9.72%

Ms. Charmaine England

Chief Growth Officer

29.06K

+5.68%

Mr. Michael E. Sneed

Independent Director

28.44K

+52.59%

Mr. Larry J. Merlo

Independent Chairman of the Board

27.46K

+124.86%

Mr. Matthew Orlando

General Counsel

25.25K

+15.69%

Ms. Melanie L. Healey

Independent Director

17.80K

+122.51%

Name

Name/Position

Position

Shareholding

Change

Ms. Meredith (Meri) Stevens

Chief Operations Officer

64.44K

+5.82%

Mr. Carlton Lawson

Group President, Europe, Middle East and Africa and Latin America

56.32K

-14.66%

Dr. Caroline Tillett

Chief Scientific Officer

44.13K

+6.62%

Mr. Jan Meurer

Group President, North America

33.18K

+15.35%

Ms. Luani Alvarado

Chief People Officer

31.36K

+9.72%

Ms. Charmaine England

Chief Growth Officer

29.06K

+5.68%

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Face and Body Care

673.38M

18.00%

Cough, Cold and Allergy

598.56M

16.00%

Other Self Care

598.56M

16.00%

Pain Care

486.33M

13.00%

Other Essential Health

374.10M

10.00%

Other

1.01B

27.00%

No Data

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Face and Body Care

673.38M

18.00%

Cough, Cold and Allergy

598.56M

16.00%

Other Self Care

598.56M

16.00%

Pain Care

486.33M

13.00%

Other Essential Health

374.10M

10.00%

Other

1.01B

27.00%

Shareholding Stats

Updated: Sun, Aug 17

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

12.11%

T. Rowe Price Associates, Inc.

8.56%

State Street Global Advisors (US)

5.99%

BlackRock Institutional Trust Company, N.A.

4.99%

MFS Investment Management

4.57%

Other

63.78%

Shareholders

Proportion

The Vanguard Group, Inc.

12.11%

T. Rowe Price Associates, Inc.

8.56%

State Street Global Advisors (US)

5.99%

BlackRock Institutional Trust Company, N.A.

4.99%

MFS Investment Management

4.57%

Other

63.78%

Shareholder Types

Shareholders

Proportion

Investment Advisor

57.82%

Investment Advisor/Hedge Fund

30.21%

Hedge Fund

5.55%

Research Firm

3.54%

Pension Fund

1.84%

Sovereign Wealth Fund

1.44%

Bank and Trust

1.26%

Family Office

0.23%

Family Office

0.19%

Institutional Shareholding

Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

2098

1.93B

100.46%

-321.30M

2025Q1

2078

1.95B

101.47%

-298.35M

2024Q4

1944

1.96B

102.60%

-253.31M

2024Q3

1828

1.91B

99.61%

-331.64M

2024Q2

1723

1.90B

99.19%

-79.08M

2024Q1

1598

1.90B

99.47%

-51.94M

2023Q4

1442

1.89B

98.66%

-22.82M

2023Q3

1206

1.90B

99.22%

-343.08M

2023Q2

232

1.95B

101.85%

+1.90B

2023Q1

0.00%

-14.23K

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

228.31M

11.89%

+10.60M

+4.87%

Mar 31, 2025

T. Rowe Price Associates, Inc.

208.36M

10.85%

-33.69M

-13.92%

Mar 31, 2025

State Street Global Advisors (US)

120.27M

6.26%

-134.23K

-0.11%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

94.32M

4.91%

+1.26M

+1.36%

Mar 31, 2025

MFS Investment Management

93.09M

4.85%

-771.33K

-0.82%

Mar 31, 2025

Fidelity Management & Research Company LLC

92.37M

4.81%

-13.82M

-13.02%

Mar 31, 2025

Geode Capital Management, L.L.C.

48.40M

2.52%

+2.33M

+5.05%

Mar 31, 2025

Wellington Management Company, LLP

61.47M

3.2%

-6.89M

-10.08%

Mar 31, 2025

American Century Investment Management, Inc.

21.83M

1.14%

+2.96M

+15.70%

Mar 31, 2025

Related ETFs

Updated: Sat, Sep 6

Name

Proportion

Renaissance IPO ETF

9.63%

American Century Focused Large Cap Value ETF

3.63%

Brookstone Value Stock ETF

3.22%

TBG Dividend Focus ETF

3.15%

Cullen Enhanced Equity Income ETF

3.02%

ProShares Ultra Consumer Staples

2.63%

Invesco S&P 500 Equal Weight Consumer Staples ETF

2.54%

Consumer Staples Select Sector SPDR Fund

2.52%

VanEck Morningstar Wide Moat Value ETF

2.04%

iShares US Consumer Staples ETF

1.77%

Renaissance IPO ETF

Proportion9.63%

American Century Focused Large Cap Value ETF

Proportion3.63%

Brookstone Value Stock ETF

Proportion3.22%

TBG Dividend Focus ETF

Proportion3.15%

Cullen Enhanced Equity Income ETF

Proportion3.02%

ProShares Ultra Consumer Staples

Proportion2.63%

Invesco S&P 500 Equal Weight Consumer Staples ETF

Proportion2.54%

Consumer Staples Select Sector SPDR Fund

Proportion2.52%

VanEck Morningstar Wide Moat Value ETF

Proportion2.04%

iShares US Consumer Staples ETF

Proportion1.77%

Dividend

A total of 2.32B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Jan 16, 2025

KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025

Feb 12, 2025

Feb 26, 2025

Feb 12, 2025

Oct 17, 2024

KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024

Nov 13, 2024

Nov 27, 2024

Nov 13, 2024

Jul 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024

Aug 14, 2024

Aug 28, 2024

Aug 14, 2024

Apr 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024

May 08, 2024

May 22, 2024

May 07, 2024

Jan 25, 2024

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024

Feb 14, 2024

Feb 28, 2024

Feb 13, 2024

Oct 26, 2023

KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023

Nov 08, 2023

Nov 22, 2023

Nov 07, 2023

Jul 20, 2023

KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023

Aug 28, 2023

Sep 07, 2023

Aug 25, 2023

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

KeyAI

